Tufts Clinical and Translation Science Institute (UL1)

塔夫茨临床与翻译科学研究所 (UL1)

• 批准号: 7919757
• 负责人: Harry P. Selker
• 金额: $ 40万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-25 至 2011-09-24
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7919757
• 关键词: Tufts; Clinical; Translation; Science; Institute

Leveraging Tufts University's excellent resources, traditions of multidisciplinary collaboration, generation of novel research methods, and academic innovation, including the first MS/PhD Clinical Research (CR) Program in a graduate school of biomedical sciences, we will establish the Tufts Clinical and Translational Science Institute (CTSI). This will unite eight Tufts Schools (Arts & Sciences, Citizenship and Public Service, Dental Medicine, Engineering, Graduate Biomedical Sciences, Medicine, Nutrition, and Veterinary Medicine), eight affiliated hospitals, the Tufts Center for the Study of Drug Development, the USDA Human Nutrition Research Center on Aging at Tufts, and the Tufts-New England Medical Center (Tufts-NEMC) Institute for Clinical Research and Health Policy Studies. This will: 1) Create a new home for clinical and translational clinical research (CTR), a cross-University, cross-affiliate Tufts CTSI, headed by an international leader in CTR who will report to the University Provost; 2) Create eight research resource Components suggested by the CTSA RFA, plus four based on special Tufts strengths; 3) Enhance and expand the "CR Portal" at Tufts- NEMC into a Tufts-wide "CTSI Portal" that provides coordinated and mentored University- and affiliate-wide access to CTSI Components and other resources; 4) Create activities, processes, and new information systems that will support and promote collaborative cross-disciplinary full-spectrum translational research; and 5) Enhance our MS/PhD CR Program by a) adding to the existing four Concentrations (Clinical Investigation, Epidemiology/Biostatistics, Health Services and Outcomes Research, and Medical Informatics), Concentrations in Bench-to-Bedside Translational Research and in Evidence-Based Medicine; b) developing distance learning to extend the Program to fellows, K12 scholars, and other faculty at Tufts affiliates across Massachusetts; c) creating the joint Pfizer Tufts Career Development Awards; d) preparing predoctoral tracks for Tufts MD, DMD, and DVM students to also get a CR MS or PhD; e) developing joint tracks for students to get an MS in Nutrition or in Biomedical Engineering with a PhD in CR; and f) developing a program to generate interest in CTR among students from underrepresented minority groups. In all aspects of training, research support, and organizational development, the Tufts CTSI will support and instill the culture of cooperative interdisciplinary research, a home without walls, for CTR Tufts-wide.

利用塔夫茨大学的优秀资源、多学科合作的传统、产生 新的研究方法和学术创新，包括第一个硕士/博士临床研究(CR) 计划在生物医学研究生院，我们将建立塔夫茨临床和翻译 科学研究所(CTSI)。这将联合八所塔夫茨学校(文理、公民和公共服务、 牙科医学、工程学、生物医学研究生、医学、营养学和兽医)， 八家附属医院，塔夫茨药物开发研究中心，美国农业部人类营养 塔夫茨老龄化研究中心和塔夫茨-新英格兰医学中心(塔夫茨-NEMC)研究所 临床研究和卫生政策研究。这将：1)为临床和翻译创造新的家园 临床研究(CTR)，一个跨大学，跨分支机构的塔夫茨CTSI，由一位国际领先的 CTR将向大学教务长报告；2)创建八个研究资源组件，建议 CTSA RFA，外加基于塔夫茨特殊优势的四个；3)增强和扩展塔夫斯的“CR门户”- 将NEMC整合到Tuft范围内的“CTSI门户”，在大学和附属机构范围内提供协调和指导 访问CTSI组件和其他资源；4)创建活动、流程和新信息 支持和促进合作的跨学科全谱翻译研究的系统； 和5)通过a)增加现有的四个浓度(临床)来增强我们的MS/PHD CR计划 调查、流行病学/生物统计学、卫生服务和结果研究以及医学 信息学)，床边翻译研究和循证医学中的浓度； B)发展远程学习，将该方案扩展到研究员、K12学者和塔夫茨大学的其他教员 马萨诸塞州的分支机构；c)创建联合辉瑞塔夫茨职业发展奖；d)准备 为Tuft MD、DMD和DVM学生提供博士前跟踪，以获得CR MS或博士学位；e)开发联合 为学生提供获得营养学或生物医学工程硕士学位并获得CR博士学位的途径；以及f) 制定一项计划，以激发少数族裔学生对CTR的兴趣。 在培训、研究支持和组织发展的所有方面，塔夫茨CTSI将支持 并为CTR Tuft-wide灌输合作跨学科研究的文化，一个没有围墙的家。